Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,778
datasets available to search
ShareScore release 0.9.0
Dataset results
34,778 results for “Diseases”
Microbiome network connectivity and composition linked to disease resistance in strawberry plants
<p>The two R data files correspond phyloseq objects used in the study. The file phyloseq_nochim_silva.RData and phyloseq_nochim_unite.RData correspond to bacterial and fungal phyloseq objects, respectively. Both objects include count table, taxonomy table and metadata information. </p>
Large scale eDNA monitoring of multiple aquatic pathogens as a tool to provide risk maps for wildlife diseases
<p>Multiple parasites and pathogens cause disease in aquatic wildlife and in aquaculture species, generating a need for monitoring and management. Conventional disease monitoring methods involve laborious, costly and invasive capture and examination of host species, and require specialised expertise for every host and pathogen of interest. These restrictions could be alleviated by using pathogen detection techniques based on environmental DNA that provide simultaneous surveys of multiple aquatic pathogens across different host taxa. This would also be valuable for approaches employing parasite diversity as bioindicators of ecosystem disturbance, which suffer from similar restrictions. Here, we tested the potential for simultaneous detection of four wildlife pathogens in water samples from 280, mainly riverine, sites across Switzerland. We targeted the crayfish pathogen <em>Aphanomyces astaci, </em>the amphibian pathogen <em>Batrachochytrium dendrobatidis, </em>and the fish pathogens <em>Saprolegnia parasitica</em> and <em>Tetracapsuloides bryosalmonae</em>. The eDNA detection showed a widespread distribution of <em>A. astaci</em>, <em>S. parasitica</em> and <em>T. bryosalmonae</em>, although <em>A. astaci </em>and <em>T. bryosalmonae</em> were not detected in some alpine river catchments. <em>B. dendrobatidis</em> was detected only rarely, which was expected since the sampling did not target amphibian breeding sites. Co-detection rates were higher in rivers than in lakes, likely reflecting the habitat preferences and distributions of the host species. We discuss the advantages and limitations of eDNA-based pathogen monitoring and list a set of recommendations for managers. Our study illustrates how eDNA-based techniques can monitor several pathogen species concurrently, thus facilitating more comprehensive disease monitoring schemes. Combined with metabarcoding approaches in the future, eDNA based sampling and detection can facilitate the incorporation of parasite and pathogen occurrence and diversity as an indicator for aquatic ecosystem health, and for revealing the hidden biodiversity and structure of parasite communities.</p>
KidDO progress presentation 2022: Metabolic Targets for Therapeutic Intervention in Kidney Disease
<p>This is a recorded talk with head of the KidDO project - Robert Fenton - where he presents the latest project progress.</p> <p>The talk was given at one of ODIN's (the Open Discovery Innovation Network) Knowledge Sharing Events in May 2022.</p> <p> </p> <p> </p>
Compensatory recruitment unlikely in high elevation amphibian populations challenged with disease
<p>Population-level variation in host responses to disease can be observed across a wide array of host-pathogen systems. Some host populations are extirpated, some persist at lower densities or abundances, and others rebound to pre-disease levels. Understanding the causes of this variation, and the mechanisms of successful persistence, can serve as vital information for species conservation. One such mechanism of population persistence that has gained support in the amphibian <em>Batrachochytrium dendrobatidis</em> (Bd) host-pathogen system is the demographic process of compensatory recruitment. Host populations may persist by increasing recruitment to compensate for reduced survival due to infection, thus limiting the negative effects of the disease on population trajectories. However, high-elevation amphibian populations are inherently vulnerable to stochastic processes and may be limited in their ability to exhibit compensatory recruitment relative to lower-elevation populations.</p> <p>We use long-term mark-recapture data from five populations of boreal toads (<em>Anaxyrus boreas boreas</em>), across an elevational gradient in Colorado, before and after pathogen arrival to assess whether populations can persist with Bd via compensatory recruitment.</p> <p>Prior to Bd arrival, we found a life history tradeoff between survival and recruitment across elevations, where high-elevation toads have high survival but lower recruitment and vice versa at lower elevations.</p> <p>Bd arrival had a strong negative effect on apparent annual survival and recruitment, and led to negative population growth rates and dramatically reduced host abundances. The data did not support the occurrence of compensatory recruitment.</p> <p>Synthesis and applications. Our unique dataset suggests that demographic responses to pathogens may be environmentally (i.e., elevationally) context-dependent and highlights the value of long-term monitoring. We recommend that practitioners verify that potential persistence mechanisms occur across multiple populations and relevant environmental gradients to counter any assumptions of the mechanism existing species-wide. Quantifying any variation in population responses to disease will aid in understanding the bounds of such persistence mechanisms, and identify particularly vulnerable populations where mechanisms are non-existent.</p>
Occupational and environmental diseases by operating results report of 43 files from Health Data Center (HDC)
<p>Data used in this study were from the Health Data Center (HDC); permission to use these data can be requested from the Health Data Center (HDC), Ministry of Public Health Thailand. <br> This study got approval from the Health Data Center (HDC)(reference no.0212-78) to use the data on pesticide pollutions (insecticide and herbicide) in provinces years 2018-2020 excluding Bangkok because data from Bangkok were not reported on HDC. Included pesticide poisoning from DIAGNOSIS_OPD and DIAGNOSIS_IPD files which used to DIAGCODE were 'T600','T601','T602','T603','T604','T608','T609' without the X68 code. </p> <p><strong>File descriptions</strong>: The pesticide pollutions (pesticide-induced, insecticide, and herbicide) in provinces years 2018-2020:<br> cwt : post code <br> cwt_n : province names<br> 63_pop : population in 2020<br> N63_pesticide : pesticide-induced patients in 2020<br> P63_pesticide : prevalence of pesticide-induced patients in years 2020<br> N63_Insecticide : insecticide patients in 2020<br> P63_Insecticide : prevalence of insecticide patients in years 2020<br> N63_Herbicide : herbicide patients in 2020<br> P63_Herbicide : prevalence of herbicide patients in years 2020<br> N63_Other : other pesticide patients in 2020<br> P63_Other : prevalence of other pesticide patients in years 2020<br> 62_pop : population in 2019<br> N62_pesticide : pesticide-induced patients in 2019<br> P62_pesticide : prevalence of pesticide-induced patients in years 2019<br> N62_Insecticide : insecticide patients in 2019<br> P62_Insecticide : prevalence of insecticide patients in years 2019<br> N62_Herbicide : herbicide patients in 2019<br> P62_Herbicide : prevalence of herbicide patients in years 2019<br> N62_Other : other pesticide patients in 2019<br> P62_Other : prevalence of other pesticide patients in years 2019<br> 61_pop : population in 2018<br> N61_pesticide : pesticide-induced patients in 2018<br> P61_pesticide : prevalence of pesticide-induced patients in years 2018<br> N61_Insecticide : insecticide patients in 2018<br> P61_Insecticide : prevalence of insecticide patients in years 2018<br> N61_Herbicide : herbicide patients in 2018<br> P61_Herbicide : prevalence of herbicide patients in years 2018<br> N61_Other : other pesticide patients in 2018<br> P61_Other : prevalence of other pesticide patients in years 2018</p> <p>P3y_pesticide : average prevalence of pesticide-induced patients from 2018 to 2020<br> P3y_Insecticide : average prevalence of insecticide patients from 2018 to 2020<br> P3y_Herbicide : average prevalence of herbicide patients from 2018 to 2020<br> P3y_Other : average prevalence of other pesticide patients from 2018 to 2020</p>
Disease management during bloom affects the floral microbiome but not pollination in a mass-flowering crop
<p>Flowering crops are heavily managed during bloom to both promote pollination and prevent disease. Disease management practices can alter the floral microbiome, including pathogens and non-target microbes. However, whether agrochemical presence or altered microbiome composition affect pollinator foraging and pollination services is unclear.</p> <p>We assessed the effects of orchard management tactics and landscape context on the flower microbiome in almond, <em>Prunus dulcis</em>. Fourteen orchards (5 conventional, 4 organic, 5 conventional with habitat augmentation) were sampled at early and peak bloom to characterize bacterial and fungal communities associated with floral tissues. The surveys were complemented by an artificial flower experiment to assess the effects of fungicides and microbes on honey bee foraging. Finally, a field trial was conducted to test the effects of fungicides and microbes on pollination. </p> <p>As bloom progressed, bacterial and fungal abundance and diversity increased across all floral tissue types and management strategies. The magnitude by which microbial abundance and diversity were affected varied, with proximity to apiaries and orchard management having notable effects on bacteria and fungi, respectively.</p> <p>Experiments revealed that fungicides reduced nectar removal by honey bees; however, neither fungicide nor microbe treatments affected pollination, as measured through pollen tube initiation and growth. </p> <p><strong>Synthesis and applications</strong>: Our results reveal that microbiota associated with flowers of a pollinator-dependent crop are temporally dynamic and sensitive to management practices. However, pollination services in almonds may be resilient to both agrochemical disturbance and microbial augmentation of flowers, the latter of which may become more prominent as microbial solutions to disease management are embraced in agroecosystems.</p>
Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases - Individual patient data
<p>This dataset contains individual subject data for hemodynamic measurements assessed in the present study.</p>
MicrobiomeHD: the human gut microbiome in health and disease
<p><strong>Overview</strong></p> <p>MicrobiomeHD is a standardized database of human gut microbiome studies in health and disease. This database includes publicly available 16S data from published case-control studies and their associated patient metadata. Raw sequencing data for each study was downloaded and processed through a standardized pipeline.</p> <p>To be included in MicrobiomeHD, datasets have:</p> <ul> <li>publicly available raw sequencing data (fastq or fasta)</li> <li>publicly available metadata with at least case and control labels for each patient</li> </ul> <p>Currently, MicrobiomeHD is focused on stool samples. Additional samples may be included in certain datasets, as indicated in the metadata.</p> <p><strong>Files</strong></p> <p>Additional information about the datasets included in this MicrobiomeHD release are in the MicrobiomeHD github repo <a href="https://github.com/cduvallet/microbiomeHD">https://github.com/cduvallet/microbiomeHD</a>, in the file <em>db/dataset_info.yaml</em>. Top-level identifiers correspond to dataset IDs labeled by disease_first-author. For the most part, sample sizes in the yaml file are those that were described in the papers, and may not exactly reflect the actual data (due to missing/extra data, samples which didn't pass quality control, etc).</p> <p>Each dataset was downloaded and processed through a standardized pipeline. The raw processing results are available in the *.tar.gz files here. Each file has the same directory structure and files, as described in the pipeline documentation: <a href="http://amplicon-sequencing-pipeline.readthedocs.io/en/latest/output.html">http://amplicon-sequencing-pipeline.readthedocs.io/en/latest/output.html</a>.</p> <p>Specific files of interest in each *.tar.gz folder include:</p> <ul> <li><strong>summary_file.txt</strong>: this file contains a summary of all parameters used to process the data</li> <li><strong>datasetID.metadata.txt</strong>: the metadata associated with the samples. Note that some samples in the metadata may not have sequencing data, and vice versa.</li> <li><strong>RDP/datasetID.otu_table.100.denovo.rdp_assigned</strong>: the 100% OTU tables with Latin taxonomic names assigned using the RDP classifier (c = 0.5).</li> <li><strong>datasetID.otu_seqs.100.fasta</strong>: representative sequences for each OTU in the 100% OTU table. OTU labels in the OTU table end with <code>d__denovoID</code> - these denovoIDs correspond to the sequences in this file.</li> <li><strong>README.txt</strong>: additional information about steps taken to download and process each dataset, as needed.</li> </ul> <p>The raw data was acquired as described in the supplementary materials of Duvallet et al.'s "Meta analysis of microbiome studies identifies shared and disease-specific patterns" and, when available, the respective dataset README files.</p> <p>Raw sequencing data was processed with the Alm lab's in-house 16S processing pipeline: <a href="https://github.com/thomasgurry/amplicon_sequencing_pipeline">https://github.com/thomasgurry/amplicon_sequencing_pipeline</a></p> <p>Pipeline documentation is available at: <a href="http://amplicon-sequencing-pipeline.readthedocs.io/">http://amplicon-sequencing-pipeline.readthedocs.io/</a></p> <p>Metadata was extracted from the original papers and/or data sources, and formatted manually. When possible, these steps are documented in each dataset's associated README.txt file.</p> <p><strong>Contributing</strong></p> <p>MicrobiomeHD is a resource that can be used to extract disease-specific microbiome signals in individual case-control studies. Many microbes respond non-specifically to health and disease, and the majority of bacterial associations within individual studies overlap with this non-specific response. Researchers should cross-check their results with the data presented here to ensure that their identified microbial associations are specific to their disease under study.</p> <p>We provide an updated list of non-specific microbes here, as well as the raw OTU tables for anyone who wishes to reproduce and adapt this analysis to their study question.</p> <p>If you would like to include your case-control dataset in MicrobiomeHD, please email ejalm[at]mit.edu and duvallet[at]mit.edu.</p> <p>For us to process your data through our standard pipeline, you will need to provide the following files and information about your data:</p> <ul> <li>raw sequencing data in fastq or fasta format (preferably fastq)</li> <li>information about which processing steps will be required (e.g. removing primers or barcodes, merging paired-end reads, etc)</li> <li>sample IDs associated with the sequencing data (either mapped to barcodes still in the sequences, or to each de-multiplexed sequencing file)</li> <li>case/control metadata of each sample</li> <li>other relevant metadata (e.g. sampling site, if not all samples are stool; sampling time point, if multiple samples per patient were taken; etc)</li> </ul> <p>By using MicrobiomeHD in your own analyses, you agree to contribute your dataset to this database and to make your raw sequencing data (i.e. fastq files) publicly available.</p> <p><strong>Citing MicrobiomeHD</strong></p> <p>The MicrobiomeHD database and original publications for each of these datasets are described in Duvallet et al. (2017): <a href="http://dx.doi.org/10.1038/s41467-017-01973-8">http://dx.doi.org/10.1038/s41467-017-01973-8</a></p> <p>Duvallet, C., Gibbons, S. M., Gurry, T., Irizarry, R. A., & Alm, E. J. (2017). Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. <em>Nature communications</em>, 8(1), 1784.</p> <p>If you use any of these datasets in your analysis, please cite both MicrobiomeHD (Duvallet et al. (2017)) and the original publication for each dataset that you use.</p> <p>The code used to process and analyze this data in the paper is available on github: <a href="https://github.com/cduvallet/microbiomeHD">https://github.com/cduvallet/microbiomeHD</a></p> <p><strong>Files</strong></p> <p><em>Data files</em></p> <p><strong>file-S3.nonspecific_genera.txt</strong>: Supplemental Table 3 from Duvallet et al. (2017), listing the non-specific health- and disease-associated microbes.<br> <strong>dataset_info.yaml</strong>: yaml file with additional dataset metadata.</p> <p><em>Datasets</em></p> <p>Note that MicrobiomeHD contains all 28 datasets from Duvallet et al. (2017), as well as additional datasets which did not meet the inclusion criteria for the meta-analysis presented in the paper. Additional information about the datasets included in this MicrobiomeHD release are in the original publications and the MicrobiomeHD github repo https://github.com/cduvallet/microbiomeHD, and in the file <em>dataset_info.yaml</em>.</p> <p>The sample sizes listed here reflect what was reported in the original publications. Some may have discrepancies between what is reported and what is in the actual data due to missing data, quality issues, barcode mismatches, etc.</p> <ul> <li><strong>asd_son_results.tar.gz</strong> (<em>asd_son</em>): NT: 44, ASD: 59 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0137725</li> </ul> </li> <li><strong>autism_kb_results.tar.gz</strong> (<em>asd_kang</em>): H: 20, ASD: 20 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0068322</li> </ul> </li> <li><strong>cdi_schubert_results.tar.gz</strong> (<em>cdi_schubert</em>): H: 155, nonCDI: 89, CDI: 94 <ul> <li>http://dx.doi.org/10.1128/mBio.01021-14</li> </ul> </li> <li><strong>cdi_vincent_v3v5_results.tar.gz</strong> (<em>cdi_vincent</em>): H: 25, CDI: 25 <ul> <li>http://dx.doi.org/10.1186/2049-2618-1-18</li> </ul> </li> <li><strong>cdi_youngster_results.tar.gz</strong> (<em>cdi_youngster</em>): H: 4, CDI: 19 <ul> <li>http://dx.doi.org/10.1093/cid/ciu135</li> </ul> </li> <li><strong>crc_baxter_results.tar.gz</strong> (<em>crc_baxter</em>): adenoma: 198, H: 172, CRC: 120 <ul> <li>http://dx.doi.org/10.1186/s13073-016-0290-3</li> </ul> </li> <li><strong>crc_xiang_results.tar.gz</strong> (<em>crc_chen</em>): H: 22, CRC: 21 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0039743</li> </ul> </li> <li><strong>crc_zackular_results.tar.gz</strong> (<em>crc_zackular</em>): adenoma: 30, H: 30, CRC: 30 <ul> <li>http://dx.doi.org/10.1158/1940-6207.CAPR-14-0129</li> </ul> </li> <li><strong>crc_zeller_results.tar.gz</strong> (<em>crc_zeller</em>): H: 75, CRC: 41 <ul> <li>http://dx.doi.org/10.15252/msb.20145645</li> </ul> </li> <li><strong>crc_zhao_results.tar.gz</strong> (<em>crc_wang</em>): H: 56, CRC: 46 <ul> <li>http://dx.doi.org/10.1038/ismej.2011.109}</li> </ul> </li> <li><strong>edd_singh_results.tar.gz</strong> (<em>edd_singh</em>): STEC: 28, CAMP: 71, SALM: 66, SHIG: 34, H: 75 <ul> <li>http://dx.doi.org/10.1186/s40168-015-0109-2</li> </ul> </li> <li><strong>hiv_dinh_results.tar.gz</strong> (<em>hiv_dinh</em>): H: 16, HIV: 21 <ul> <li>http://dx.doi.org/10.1093/infdis/jiu409</li> </ul> </li> <li><strong>hiv_lozupone_results.tar.gz</strong> (<em>hiv_lozupone</em>): H: 13, HIV: 25 <ul> <li>http://dx.doi.org/10.1016/j.chom.2013.08.006</li> </ul> </li> <li><strong>hiv_noguerajulian_results.tar.gz</strong> (<em>hiv_noguerajulian</em>): H: 34, HIV: 206 <ul> <li>https://doi.org/10.1016%2Fj.ebiom.2016.01.032</li> </ul> </li> <li><strong>ibd_alm_results.tar.gz</strong> (<em>ibd_papa</em>): IBDundef: 1, nonIBD: 24, UC: 43, CD: 23 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0039242</li> </ul> </li> <li><strong>ibd_engstrand_maxee_results.tar.gz</strong> (<em>ibd_willing</em>): CCD: 12, H: 35, ICD: 15, UC: 16, ICCD: 2 <ul> <li>http://dx.doi.org/10.1053/j.gastro.2010.08.049</li> </ul> </li> <li><strong>ibd_gevers_2014_results.tar.gz</strong> (<em>ibd_gevers</em>): H: 31, CD: 224 <ul> <li>http://dx.doi.org/10.1016/j.chom.2014.02.005</li> </ul> </li> <li><strong>ibd_huttenhower_results.tar.gz</strong> (<em>ibd_morgan</em>): H: 18, UC: 48, CD: 62 <ul> <li>http://dx.doi.org/10.1186/gb-2012-13-9-r79</li> </ul> </li> <li><strong>mhe_zhang_results.tar.gz</strong> (<em>liv_zhang</em>): CIRR: 25, H: 26, MHE: 26 <ul> <li>http://dx.doi.org/10.1038/ajg.2013.221</li> </ul> </li> <li><strong>nash_chan_results.tar.gz</strong> (<em>nash_wong</em>): H: 22, NASH: 16 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0062885</li> </ul> </li> <li><strong>nash_ob_baker_results.tar.gz</strong> (<em>nash_ob_zhu</em>): H: 16, NASH: 22, OB: 25 <ul> <li>http://dx.doi.org/10.1002/hep.26093</li> </ul> </li> <li><strong>ob_escobar_results.tar.gz</strong> (<em>ob_escobar</em>): OW: 10, H: 10, OB: 10 <ul> <li>https://doi.org/10.1186/s12866-014-0311-6</li> </ul> </li> <li><strong>ob_goodrich_results.tar.gz</strong> (<em>ob_goodrich</em>): OW: 322, H: 433, OB: 183 <ul> <li>http://dx.doi.org/10.1016/j.cell.2014.09.053</li> </ul> </li> <li><strong>ob_gordon_2008_v2_results.tar.gz</strong> (<em>ob_turnbaugh</em>): H: 61, OB: 219 <ul> <li>http://dx.doi.org/10.1038/nature07540</li> </ul> </li> <li><strong>ob_jumpertz_results.tar.gz</strong> (<em>ob_jumpertz</em>): H: 12, OB: 9 <ul> <li>http://ajcn.nutrition.org/content/early/2011/05/03/ajcn.110.010132</li> </ul> </li> <li><strong>ob_ross_results.tar.gz</strong> (<em>ob_ross</em>): H: 26, OB: 37 <ul> <li>http://dx.doi.org/10.1186/s40168-015-0072-y</li> </ul> </li> <li><strong>ob_wu_results.tar.gz</strong> (<em>ob_wu</em>): bmi_data: 101 <ul> <li>http://dx.doi.org/10.1126/science.1208344</li> </ul> </li> <li><strong>ob_zeevi_results.tar.gz</strong> (<em>ob_zeevi</em>): bmi_data: 870 <ul> <li>http://dx.doi.org/10.1016/j.cell.2015.11.001</li> </ul> </li> <li><strong>ob_zupancic_results.tar.gz</strong> (<em>ob_zupancic</em>): H: 167, OB: 117 <ul> <li>http://dx.doi.org/10.1371/journal.pone.0043052</li> </ul> </li> <li><strong>par_scheperjans_results.tar.gz</strong> (<em>par_scheperjans</em>): H: 72, PAR: 72 <ul> <li>http://dx.doi.org/10.1002/mds.26069</li> </ul> </li> <li><strong>ra_littman_results.tar.gz</strong> (<em>art_scher</em>): H: 28, NORA: 44, CRA: 26, PSA: 16 <ul> <li>http://dx.doi.org/10.7554/eLife.01202</li> </ul> </li> <li><strong>t1d_alkanani_results.tar.gz</strong> (<em>t1d_alkanani</em>): T1D: 21, H: 55, T1D_new-onset: 35 <ul> <li>http://dx.doi.org/10.2337/db14-1847</li> </ul> </li> <li><strong>t1d_mejialeon_results.tar.gz</strong> (<em>t1d_mejialeon</em>): T1D: 21, H: 8 <ul> <li>http://dx.doi.org/10.1038/srep03814</li> </ul> </li> </ul> <p><strong>Version changes</strong></p> <p>Version 3</p> <ul> <li>added missing ob_escobar metadata</li> <li>added ob_jumpertz, ob_zeevi, and ob_wu</li> <li>added README.txt files to all folders, with info about data downloading and processing steps</li> <li>removed deprecated quality_control folders from all dataset results</li> <li>changed Supplemental File S3 to the most updated version of non-specific genera (as published in Duvallet et al 2017)</li> </ul> <p>Version 2</p> <ul> <li>added crc_zhu and ob_escobar datasets</li> <li>added list of core genera and dataset_info.yaml</li> </ul>
Meta-analysis of the human upper respiratory tract microbiome reveals robust taxonomic associations with health and disease.
<p>Contains all intermediate data files for the article <strong>Meta-analysis of the human upper respiratory tract microbiome reveals robust taxonomic associations with health and disease, </strong>Quinn-Bohmann et al. 2024. </p> <p>NP and OP refers to nasopharyngeal or oropharyngeal samples, respectively. As some study identifiers are duplicated across these groups, qiime_NP and qiime_OP should be unzipped in distinct directories. The same applies for metadata data files. </p> <p>Analyses of these data can be found at https://github.com/Gibbons-Lab/2023_URTmetaanalysis/tree/main. </p>
Data from: Signature of altered retinal microstructures and electrophysiology in schizophrenia spectrum disorders is associated with disease severity and polygenic risk
<p>This dataset contains supporting data for the publication: </p> <p>Boudriot, E.<em> et al.</em> Signature of altered retinal microstructures and electrophysiology in schizophrenia spectrum disorders is associated with disease severity and polygenic risk. <em>Biological Psychiatry</em><span> </span><a href="https://doi.org/10.1016/j.biopsych.2024.04.014">https://doi.org/10.1016/j.biopsych.2024.04.014</a></p> <p> </p> <p>Files:</p> <ul> <li><em>clinical.csv </em>contains data from clinical assessment and polygenic risk scores for schizophrenia</li> <li><em>ophthalmic_examination.csv </em>contains data on spherical equivalent, intraocular pressure and visual acuity</li> <li><em>oct.csv </em>contains segmentation output from Iowa Reference Algorithms</li> <li><em>erg.csv </em>contains pre-processed ERG data for the four ERG conditions</li> <li><em>mri.csv </em>contains ICV-corrected MRI volumes</li> </ul>
Data from: The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease
<p>The behavior of the comprehensive circulating renin‐angiotensin system (RAS) in dogs with myxomatous mitral valve disease (MMVD) before the onset of congestive heart failure remains largely unexplored.</p> <p>Hypothesis/Objectives: The classical and alternative RAS activity and aldosterone concentrations will be significantly higher in dogs with American College of Veterinary Internal Medicine (ACVIM) stage B2 MMVD compared to normal dogs and dogs with ACVIM stage B1 MMVD.</p> <p>Animals: One hundred seventeen client‐owned dogs (normal = 60; B1 = 31; B2 = 26).</p> <p>Methods: Prospective observational study. Angiotensin peptides (AP) and aldosterone concentrations were measured using liquid chromatography and mass spectrometry. Angiotensin converting enzymes 1 and 2 (ACE, ACE2) and renin activity surrogates were calculated from AP concentrations. Equilibrium dialysis (ED) and immediate protease inhibition (PI) methods of AP quantification were compared in 14 healthy dogs.</p> <p>Results: Core RAS activity and aldosterone concentrations did not differ among the 3 groups. However, the balance between the alternative and classical RAS differed, with dogs with stage B2 MMVD having significantly higher ACE2 activity surrogate (ACE2surr) when compared to normal dogs (adjusted P = .02; ratio of medians for ACE2surr [B2:normal], 1.89; 95% confidence interval [CI]: 1.4‐2.6). The ED and PI methods of AP quantification were highly correlated (AngI, r = .9, P < .0001; AngII, r = .8, P = .001).</p> <p>Conclusions and Clinical Importance: Circulating alternative RAS activity, specifically the surrogate measure of ACE2 activity, was increased in dogs with stage B2 MMVD as compared to normal dogs. Equilibrium dialysis results are analogous to immediate protease inhibition in dogs.</p>
Data from: The potential of undersown species identity vs. diversity to manage disease in crops
<p>In the absence of chemical control with its negative side effects, fungal pathogens can cause large yield losses, requiring us to develop agroecosystems that are inherently disease resistant. Grassland biodiversity experiments often find plant species diversity to reduce pathogen pressure, but whether incorporating high biodiversity levels in agricultural fields have similar effects remains largely unknown.</p> <p>We tested if undersown plant species diversity could reduce barley disease, and whether the effect was mediated through above- or belowground mechanisms, by combining an agricultural field trial with a soil transplant experiment.</p> <p>As predicted, barley disease decreased in the presence of undersown plants. Undersown species richness had no effect, but their abundance led to early season disease reduction. Aboveground mechanisms underpinned this disease reduction. Barley yield slightly decreased with increasing undersown species richness, and undersown species varied in their impact on yield.</p> <p>We identified two undersown species, <em>Trifolium repens</em> and <em>T. hybridum</em>, that contributed most to disease reduction and had the potential to increase barley yield. Furthermore, our results indicate that aboveground mechanisms caused this. We show that agroecosystem functioning can be improved without trade-offs on yield by targeted selection of undersown species.</p>
Exome sequence analysis identifies rare coding variants associated with a machine learning-based marker for coronary artery disease.
<p>*.sh and *.R are codes to test rare coding variants for association with ISCAD.</p> <p>Petrazzini_etal_2024_*_level_meta_analysis.txt.gz are summary statistics of variant- and gene-level associations of rare coding variants in the exome sequences of 604,914 individuals with an in-silico score for coronary artery disease (ISCAD).</p> <p>Chromosomal positions are mapped to the GRCh38 (hg38) human genome reference.</p> <p>Directions of effect correspond to associations in the UK Biobank, the All of Us Research Program, the BioMe Biobank sample 1 and the BioMe Biobank sample 2, in that order.</p>
Psoriatic arthritis disease subtypes are phenocopied in a novel humanized murine model of psoriasis and joint inflammation
<p><em><span>Data processing and analysis</span></em></p> <p><span>Data normalization, quality control, and analysis was conducted by the UPMC Hillman Cancer Bioinformatics Services. Following the GeoMX NGS pipeline (<span>sequencing saturation 92%±0.12% (mean±S.E.M)), t</span>he resulting read count matrix was passed through robust QC procedure to remove ROIs of low surface area (<5000 µm<sup>2</sup>) or low perfect aligned reads (<80%), and probes of low quality or identified as global or local outliers (fails Grubbs outlier test in ≥ 20% segments). The remaining data were back-ground subtracted and Q3 normalized to house-keeping genes. ROIs were considered positive for CD8 T cells if their CD8 memory T cell deconvolution fraction was > 0 (R, spatialDecon, CellProfileLibrary; Human Adult ImmuneTumor_safeTME profile). Genes differentially expressed between groups of interest were detected using gene-wise linear modeling in R (edgeR, limma v3.50.3), with p-value adjusted for false discovery rate. Contrasts of groups were performed using t-tests at a significance level of 0.05.</span></p>
Fig. 1 in Histopatological effects of bleaching and disease on the coral Siderastrea stellata from coastal reefs of Brazil
Fig. 1. Areas where corals were sampled, Ponta do SeiXas, state of ParaÍba, Brazil.
Gut microbiome in the Graves' disease: comparison before and after anti-thyroid drug treatment
<p>Several studies have explored the link between the gut microbiome and Graves's disease (GD) but lacked data on microbiome changes following anti-thyroid drug (ATD) treatment. Stool samples from 29 newly diagnosed GD patients were analyzed before and after 6 months of ATD treatment. Results showed a significant decrease in microbial diversity in GD patients, which increased after treatment, resembling healthy levels. GD patients had lower levels of Firmicutes and higher levels of Bacteroidota, which normalized post-treatment. Specific microbial changes were associated with hyperthyroid symptoms. The study suggests the gut microbiome's involvement in GD pathogenesis and potential restoration with treatment.</p>
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis
<p><span>Retinal optical coherence tomography has been identified as biomarker for disease progression in relapsing-remitting multiple sclerosis (RRMS), while the dynamics of retinal atrophy in progressive MS are less clear. We investigated retinal layer thickness changes in RRMS, </span><span>primary and secondary progressive MS (PPMS, SPMS)</span><span>, and their prognostic value for disease activity. Here, we analyzed 2651 OCT measurements of 195 RRMS, 87 SPMS, 125 PPMS patients, and 98 controls from five German MS centers after quality control. Peripapillary and macular retinal nerve fiber layer (pRNFL, mRNFL) thickness </span><span>predicted</span><span> future relapses in all MS and RRMS patients while mRNFL</span><span> and </span><span>ganglion cell-inner plexiform layer (GCIPL) </span><span>thickness predicted </span><span>future </span><span>MRI activity </span><span>in RRMS (mRNFL, GCIPL) and PPMS (GCIPL). mRNFL thickness </span><span>predicted </span><span>future disability progression </span><span>in PPMS.</span><span> </span><span>However, thickness change rates were subject to considerable amounts of measurement variability. In conclusion, retinal degeneration, most pronounced of pRNFL and GCIPL, occurs in all subtypes. Using the current state of technology, longitudinal assessments of retinal thickness may not be suitable on a single patient level.</span></p>
Immune-mediated hematological disease in dogs is associated with alterations of the fecal microbiota: a pilot study
<div> <h3>Background</h3> <p>The dog is the most popular companion animal and is a valuable large animal model for several human diseases. Canine immune-mediated hematological diseases, including immune-mediated hemolytic anemia (IMHA) and immune thrombocytopenia (ITP), share many features in common with autoimmune hematological diseases of humans. The gut microbiome has been linked to systemic illness, but few studies have evaluated its association with immune-mediated hematological disease. To address this knowledge gap, 16S rRNA gene sequencing was used to profile the fecal microbiota of dogs with spontaneous IMHA and ITP at presentation and following successful treatment. In total, 21 affected and 13 healthy control dogs were included in the study.</p> <h3>Results</h3> <p>IMHA/ITP is associated with remodeling of fecal microbiota, marked by decreased relative abundance of the spirochete <em>Treponema</em> spp., increased relative abundance of the pathobionts <em>Clostridium septicum</em> and <em>Escherichia coli</em>, and increased overall microbial diversity. Logistic regression analysis demonstrated that <em>Treponema</em> spp. were associated with decreased risk of IMHA/ITP (odds ratio [OR] 0.24–0.34), while Ruminococcaceae UCG-009 and Christensenellaceae R-7 group were associated with increased risk of disease (OR =&thinsp;6.84 [95% CI 2–32.74] and 8.36 [95% CI 1.85–71.88] respectively).</p> <h3>Conclusions</h3> <p>This study demonstrates an association of immune-mediated hematological diseases in dogs with fecal dysbiosis, and points to specific bacterial genera as biomarkers of disease. Microbes identified as positive or negative risk factors for IMHA/ITP represent an area for future research as potential targets for new diagnostic assays and/or therapeutic applications.</p> </div>
The IDON-Peripheral Arterial Disease Study
Open the record for dataset details and reuse information.
Wiki-Disease-Benchmark
<p>This benchmark consist in 255 randomly selected disease descriptions, as of February 2024. Each disease description was labeled by two data annotators who reviewed each other's annotations to ensure accuracy and consistency across the dataset. </p> <p>This procedure involves collecting, parsing and extracting data from Wikipedia using a software routine that interfaces with an API \footnote{https://pypi.org/project/Wikipedia-API/} to systematically retrieve and collate information related to a predefined disease. Specifically, it searches for pages with a certain disease and, within those pages, extracts the "Sings and Symptoms" section.</p> <p>This process has two steps:</p> <ul> <li>Retrieve all the labels rdfs:label of triples in DBpedia \footnote{https://dbpedia.org/} that are a disease rdf:type dbo:Disease.</li> <li>With these labels, go to each page of Wikipedia and scrape the section "Signs and Symptoms".<br><br></li> </ul> <p>After extracting the text from Wikipedia, the phenotypical entities were annotated.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.